Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Innovent Announces Oral Presentations at ESMO Plenary and ESMO GI Congress on Clinical Data of IBI363 (PD-1/IL-2) and IBI343 (CLDN18.2 ADC) 2024-05-20 08:20
Qilian International plans to adjust industrial investment 2024-05-17 22:00
GV Announces Cooperation with Top 500 Company in China 2024-05-17 20:30
LiveSpo Pharma Emerges as Vietnam's Pioneer at Vitafoods Europe 2024, Unveiling Groundbreaking Research and Product Development to Reduce Antibiotic Use in Digestive and Respiratory Care 2024-05-17 18:33
Celltrion USA announces two-year data for ZYMFENTRA™(infliximab-dyyb) to be presented at Digestive Disease Week (DDW) 2024 Conference 2024-05-17 12:01
Troy Animal Healthcare Strengthens Quality Operations with Veeva Vault Quality 2024-05-17 07:00
Seegene and Springer Nature Announce Strategic Alliance 2024-05-16 21:00
Visionary Has World-Class Biochip Technology Products 2024-05-16 20:30
HSA approves GSK's Arexvy, the world's first respiratory syncytial virus (RSV) vaccine for older adults [1] 2024-05-16 10:00
EHA 2024 | Results from Five Studies of Ascentage Pharma's Key Drug Candidates Selected for Presentations at 2024 European Hematology Association Hybrid Congress 2024-05-16 09:03
/DISREGARD RELEASE: Visionary Holdings Inc./ 2024-05-15 23:01
Ractigen Therapeutics Receives IND Approval from China's NMPA to Initiate Phase 1 Clinical Trials for RAG-17 in SOD1-ALS Patients 2024-05-15 20:00
Everest Medicines Announces Commercial Launch and First Prescription for NEFECON® in Mainland China 2024-05-14 21:41
HealthTech Bioactives Partners with Abolis for Sustainable Production of High-Value Polyphenols 2024-05-14 20:00
HUB Organoids B.V. Awarded Frost & Sullivan's 2024 Technology Innovation Leadership Award for Transforming Drug Development with Highly Advanced Organoid Technology 2024-05-14 20:00
Allozymes Raises $15 Million in Series A Funding, Poised to Revolutionize Industries with Enzymatic Solutions 2024-05-14 11:24
Brii Biosciences Announces Two Breakthrough Therapy Designations for BRII-877 and BRII-835 Building on Extensive Clinical Evidence from Multiple Phase 2 Studies 2024-05-14 07:27
Mabwell Announces Clinical Trial Progress of 9MW2821 in Triple-Negative Breast Cancer 2024-05-13 22:00
SK chemicals Targets the North American market with Circular Recycling Technology participating in NPE 2024 2024-05-13 21:00
BGI-HL OHA Lab inaugurated in Harbin, initiating colorectal cancer risk assessment for 800,000 2024-05-13 13:34
1 2 3 4 5 415